tiprankstipranks
Ovid Therapeutics Inc (OVID)
NASDAQ:OVID

Compare Ovid Therapeutics (OVID) vs. Competitors

1,745 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Ovid Therapeutics
$2.75
$362.66M
-6.90
978.43%
8 Buy
0 Hold
0 Sell
Strong Buy
Opus Genetics
$5.36
$381.36M
-25.22
651.75%
9 Buy
0 Hold
0 Sell
Strong Buy
Zentalis Pharmaceuticals
$1.41
$468.85M
-0.71
484.96%
4 Buy
1 Hold
0 Sell
Strong Buy
Inhibikase Therapeutics
$1.70
$224.46M
-4.18
-8.60%
5 Buy
0 Hold
0 Sell
Strong Buy
Surrozen
$28.20
$323.93M
-0.23
207.56%
4 Buy
0 Hold
0 Sell
Strong Buy
Biomea Fusion
$1.87
$135.20M
4.86
8.09%
5 Buy
0 Hold
1 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
OVID
Ovid Therapeutics
2.75
2.46
858.19%
IRD
Opus Genetics
5.36
4.54
552.07%
ZNTL
Zentalis Pharmaceuticals
6.61
5.39
441.80%
IKT
Inhibikase Therapeutics
1.70
-0.30
-15.00%
SRZN
Surrozen
28.20
18.71
197.15%
BMEA
Biomea Fusion
1.87
0.25
15.43%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts